The Differences in the Safety and Tolerability of Immune Checkpoint Inhibitors as Treatment for Non-Small Cell Lung Cancer and Melanoma: Network Meta-Analysis and Systematic Review

• Үндсэн зохиолчид: Qing-Qing Chai (Зохиогч), Jiang-Yang Du (Зохиогч), Jun Zhu (Зохиогч), Bin Wu (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Frontiers Media S.A., 2019-10-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Background: Immune checkpoint inhibitors (ICIs) have evolved for the treatment of solid tumors. In addition to the efficacy of ICIs for cancer, the adverse events (AEs) of ICIs are also noteworthy for gradually more extensive clinical use.Objective: To conduct a systematic review and network meta-an...